Chronic Hepatitis B Infection: New Approaches towards Cure
Chronic hepatitis B virus (HBV) infection leads to the development of cirrhosis and
hepatocellular carcinoma. Lifelong treatment with nucleotides/nucleoside antiviral agents is …
hepatocellular carcinoma. Lifelong treatment with nucleotides/nucleoside antiviral agents is …
Interferon therapy improves survival in patients with hepatitis B virus-related hepatocellular carcinoma after curative surgery: a meta-analysis
JX Luo, Y Zhang, XY Hu, N Xiang - Hepatology International, 2024 - Springer
Methods MEDLINE/PubMed, Cochrane Library, EMBASE, Web of Science and CNKI were
searched for eligible studies from inception to November 2022 and a meta-analysis was …
searched for eligible studies from inception to November 2022 and a meta-analysis was …
不同抗病毒药物降低HBV 相关肝细胞癌风险的作用.
吴丽贤， 郑伟强， 韩焕钦 - Journal of Clinical Hepatology …, 2022 - search.ebscohost.com
抗病毒治疗可降低慢性乙型肝炎患者肝细胞癌(HCC) 发生的风险. 在一线抗病毒药物中,
更多的研究显示富马酸替诺福韦酯降低HCC 风险的作用可能优于恩替卡韦 …
更多的研究显示富马酸替诺福韦酯降低HCC 风险的作用可能优于恩替卡韦 …
[HTML][HTML] 干扰素-α 预防及治疗乙肝相关性肝癌的研究进展
刘辉， 鲁晓擘 - Advances in Clinical Medicine, 2023 - hanspub.org
1575387 乙型肝炎病毒(HBV) 感染引起的慢性乙型肝炎(CHB), 是导致肝细胞癌(HCC)
发生的最大病因. 干扰素-α 对慢性乙型肝炎患者有降低肝细胞癌发生风险的作用 …
发生的最大病因. 干扰素-α 对慢性乙型肝炎患者有降低肝细胞癌发生风险的作用 …
Effect of different antiviral drugs in reducing the risk of hepatitis B virus-related hepatocellular carcinoma
WU Lixian, W ZHENG, HAN Huanqin - 临床肝胆病杂志, 2022 - lcgdbzz.org
Antiviral therapy can reduce the risk of hepatocellular carcinoma (HCC) in patients with
chronic hepatitis B. As for the first-line antiviral drugs, more studies have shown that …
chronic hepatitis B. As for the first-line antiviral drugs, more studies have shown that …
[引用][C] Association between aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B
R Huang, Z Zhang, J Wang, S Zhang… - Alimentary …, 2023 - Wiley Online Library
LINKED CONTENT This article is linked to Lee et al papers. To view these articles, visit
https://doi. org/10.1111/apt. 17643 and https://doi. org/10.1111/apt. 17711
https://doi. org/10.1111/apt. 17643 and https://doi. org/10.1111/apt. 17711